Showing 1,221 - 1,240 results of 4,761 for search 'significantly ((((greater decrease) OR (((nn decrease) OR (mean decrease))))) OR (larger decrease))', query time: 0.57s Refine Results
  1. 1221
  2. 1222
  3. 1223
  4. 1224
  5. 1225
  6. 1226
  7. 1227
  8. 1228
  9. 1229
  10. 1230
  11. 1231

    Presentation 1_Ceftriaxone-associated dysbiosis decreases voriconazole bioavailability by upregulating intestinal P-glycoprotein expression through activation of the Nrf2-mediated... by Xiaokang Wang (733379)

    Published 2025
    “…</p>Key findings<p>The diversity and richness of intestinal bacteria, especially the abundance of gram-negative bacteria, were significantly decreased after ceftriaxone treatment. …”
  12. 1232

    Table 1_Ceftriaxone-associated dysbiosis decreases voriconazole bioavailability by upregulating intestinal P-glycoprotein expression through activation of the Nrf2-mediated signall... by Xiaokang Wang (733379)

    Published 2025
    “…</p>Key findings<p>The diversity and richness of intestinal bacteria, especially the abundance of gram-negative bacteria, were significantly decreased after ceftriaxone treatment. …”
  13. 1233

    Changes in best-corrected visual acuity and total area reduction ratio of the epiretinal membrane (ERM) during follow-up. by Su Hwan Park (15158181)

    Published 2025
    “…<p>(a) During the follow-up period, the stable group showed no significant change in visual acuity, whereas the progression group exhibited a decrease compared to baseline starting at 12 months, with greater changes than those in the stable group beginning at 6 months. …”
  14. 1234

    Data. by Su Hwan Park (15158181)

    Published 2025
    “…Participants in the progression group were younger (60.7 vs. 65.7 years, P = 0.015) and showed a larger BCVA change (0.20 vs. 0.04, P < 0.001) and greater ERM area decrease (34.2% vs. 11.7%, P < 0.001) during the follow-up period. …”
  15. 1235
  16. 1236
  17. 1237
  18. 1238
  19. 1239
  20. 1240

    Baseline characteristics of patients. by Su Hwan Park (15158181)

    Published 2025
    “…Participants in the progression group were younger (60.7 vs. 65.7 years, P = 0.015) and showed a larger BCVA change (0.20 vs. 0.04, P < 0.001) and greater ERM area decrease (34.2% vs. 11.7%, P < 0.001) during the follow-up period. …”